LuViva Advanced Cervical Scan
Commercial- Indications
- Cervical cancer detection
Company intelligence / Profile preview
The LuViva Advanced Cervical Scan has demonstrated the ability to detect cervical cancer up to two years earlier than conventional methods in multi-center clinical trials. In China, a recent NMPA clinical study showed better-than-projected results across all four sites. The product has been ordered for use by government healthcare systems internationally and continues to seek regulatory approvals globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guided Therapeutics.